The study to explore the effecs of miglitol and sitagliptin on the responses of active gastric inhibitory polypeptide responses and the changes in body weight and visceral fat mass in type 2 diabetic patients with obesity
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2014
At a glance
- Drugs Miglitol (Primary) ; Sitagliptin (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms MASTER
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 31 Mar 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 Aug 2011 New trial record